(86 days)
Not Found
No
The document describes standard ultrasound image processing and does not mention AI, ML, or related concepts.
No
The device is described as a "general-purpose ultrasonic imaging instrument" and a "diagnostic ultrasound system," intended for evaluation and display of anatomic structures, which indicates diagnostic rather than therapeutic use.
Yes
The device description explicitly states, "The ECO Series Diagnostic Ultrasound Systems is a very compact and portable diagnostic ultrasound system." It also mentions its use for "evaluation" of various anatomical sites by a "qualified physician."
No
The device description explicitly states it is a "diagnostic ultrasound system" with an "integrated keyboard, LED display and several interchangeable electronic-array transducers," indicating it includes significant hardware components beyond just software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states the device is for "evaluation of Fetal/OB; Abdominal (GYN & Urology); Pediatric; Small Organ (breast, testes, thyroid); Cardiac (adult & pediatric); Peripheral Vascular, Musculo-skeletal Conventional & Superficial, Transrectal and Transvaginal." This describes the use of the device to image and assess structures within the body.
- Device Description: The description details an "ultrasonic imaging instrument" that uses transducers to generate images of "anatomic structures and fluid flow within the body."
- Input Imaging Modality: The input is "Ultrasonic," which is an imaging modality used to visualize internal structures.
- Anatomical Site: The listed anatomical sites are all locations within the human body.
IVD devices are designed to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health. This device does not perform such tests; it uses ultrasound to create images of internal structures.
N/A
Intended Use / Indications for Use
The device is a general-purpose ultrasonic imaging instrument intended for use by a qualified physician for evaluation of Fetal/OB; Abdominal (GYN & Urology); Pediatric; Small Organ (breast, testes, thyroid); Cardiac (adult & pediatric); Peripheral Vascular, Musculo-skeletal Conventional & Superficial, Transrectal and Transvaginal.
Product codes
90-IYN, 90-IYO, 90-ITX
Device Description
The ECO Series Diagnostic Ultrasound Systems is a very compact and portable diagnostic ultrasound system having five variations: ECO6, ECO5, ECO3, ECO2, and ECO1, each with options and features suited for its market niche. It has an integrated keyboard, LED display and several interchangeable electronic-array transducers and provides digital acquisition, processing and display capability. The user interface includes a keyboard, an intuitive layout of specialized controls, color GUI display.
The ECO Series Models, have been designed to meet the following product safety standards: NEMA UD 2, NEMA UD 3, IEC 60601-1, IEC 60601-1-2, IEC 60601-2-37, IEC 10993-1.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasonic
Anatomical Site
Fetal/OB; Abdominal (GYN & Urology); Pediatric; Small Organ (breast, testes, thyroid); Cardiac (adult & pediatric); Peripheral Vascular, Musculo-skeletal Conventional & Superficial, Transrectal and Transvaginal.
Indicated Patient Age Range
Adult & Pediatric (for Cardiac)
Intended User / Care Setting
qualified physician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
AUG 1 2013
PREMARKET NOTIFICATION [510(k)] Summary
This Summary of Safety and Effectiveness is prepared in accordance with 21 CFR Part 807.92(c).
1. Company Name:
Chison Medical Imaging Co., Ltd. No.8, Xiang Nan Road, Shuo Fang, New District, Wuxi, China 214142 Chison Medical Imaging Co., Ltd. No.8, Xiang Nan Road, Shuo Fang, New District, Wuxi, China 214142
- Ms. Ruoli Mo Contact: Tel: +86-510-85311707, 85310593 Fax: +86-510-85310726
- U.S. Agent: Leiker Regulatory & Quality Consulting 7263 Cronin Circle Dublin, CA 94568
- Contact: Bob Leiker Tel: (925) 556-1302 Fax: (866) 718-3819
-
- Device Name: ECO Series Diagnostic Ultrasound System
Common/Usual Name: Diagnostic Ultrasound System with Accessories
Classification: Requlatory Class: II Review Category: Tier II
Classfication Name | 21 CFR Section | Product Code |
---|---|---|
Ultrasonic pulsed doppler imaging system | 892.1550 | 90-IYN |
Ultrasonic pulsed echo imaging system | 892.1560 | 90-IYO |
Diagnostic ultrasonic transducer | 892.1570 | 90-ITX |
2. Marketed Device:
K102256,GE LOGIQ e Ultrasound System
3. Device Description:
The ECO Series Diagnostic Ultrasound Systems is a very compact and portable diagnostic ultrasound system having five variations: ECO6, ECO5, ECO3, ECO2, and ECO1, each with options and features suited for its market niche. It has an integrated keyboard, LED display and several interchangeable electronic-array transducers and provides digital acquisition, processing and display capability. The user interface includes a keyboard, an intuitive layout of specialized controls, color GUI display.
The ECO Series Models, have been designed to meet the following product safety standards: NEMA UD 2, NEMA UD 3, IEC 60601-1, IEC 60601-1-2, IEC 60601-2-37, IEC 10993-1.
1
4. Indications for Use:
The device is a general-purpose ultrasonic imaging instrument intended for use by a qualified physician for evaluation of Fetal/OB; Abdominal (GYN & Urology); Pediatric; Small Organ (breast, testes, thyroid); Cardiac (adult & pediatric); Peripheral Vascular, Musculo-skeletal Conventional & Superficial, Transrectal and Transvaginal.
Comparison to Predicate Device:
The ECO Series Models is of comparable type and substantially equivalent to the GE LOGIQ i, LOGIQ e, and the Vivid e Diagnostic Ultrasound (K102256). All systems transmit ultrasonic energy into patients, then perform post processing of received echoes to generate on-screen display of anatomic structures and fluid flow within the body, and have the same intended uses and basic operating modes as the predicate device. All systems allow for specialized measurements of structures and flow, and calculations.
5. Conclusion:
The ECO Series Models is substantially equivalent in safety and effectiveness to the predicate systems. The systems are intended for diagnostic ultrasound imaging and fluid flow analysis. . The systems have the same gray-scale. The systems have acoustic output levels below the applicable FDA limits. The systems are designed to applicable electrical and physical safety standards.
End of 510(k) Summary.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA" arranged in a circular fashion around the symbol. The caduceus is depicted with three wavy lines representing the snakes, and the text is in all capital letters.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
August 1, 2013
Chison Medical Imaging Co., Ltd. % Mr. Bob Leiker Leiker Regulatory & Quality Consulting 7263 Cronin Circle DUBLIN CA 94568
Re: K131305
Trade/Device Name: ECO Series Diagnostic Ultrasound Systems Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed Doppler imaging system Regulatory Class: II Product Code: IYN, IYO, ITX Dated: April 29. 2013 Received: June 28, 2013
Dear Mr. Leiker:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
This determination of substantial equivalence applies to the following transducers intended for use with the ECO Series Diagnostic Ultrasound Systems, as described in your premarket notification:
Transducer Model Number
| C3-A
MC3-A
V6-A | L7M-A
L7S-A
R7-A | P3-A
MC6-A |
----------------------- | ------------------------ | --------------- |
---|
3
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
for
Janine M. Morris Director, Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
4
Diagnostic Ultrasound Indications For Use
1.3 Indications for Use
510(K) Number: K131305
Device Name: ECO Series Diagnostic Ultrasound Systems
Indications for use:
The device is a general-purpose ultrasonic imaging instrument intended for use by a qualified physician for evaluation of Fetal/OB; Abdominal (GYN & Urology); Pediatric; Small Organ(breast, testes, thyroid); Cardiac (adult & pediatric); Peripheral Vascular, Musculo-skeletal Conventional & Superficial, Transrectal and Transvaginal.
Prescription Use _____________________________________________________________________________________________________________________________________________________________ (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use 21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
510(k)
Section 1.3
5
Diagnostic Ultrasound Indications For Use
ECO Series Diagnostic Ultrasound Systems System:
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track 1 Only) | Specific | |||||||
(Tracks 1 & 3) | B | M | PWD | CWD | Color | |||
Doppler | Power | |||||||
(Amplitude) | ||||||||
Doppler | Other* | |||||||
Combined | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal Imaging & | ||||||||
Other | Fetal | N | N | N | N | N | Note 1 | |
Abdominal | N | N | N | N | N | Note 1 | ||
Intra-operative (Specify) | ||||||||
Intra-operative (Neuro) | ||||||||
Laparoscopic | ||||||||
Pediatric | N | N | N | N | N | Note 1 | ||
Small Organ(1) (Specify) | N | N | N | N | N | Note 1 | ||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | N | N | N | N | N | Note 1 | ||
Trans-vaginal | N | N | N | N | N | Note 1 | ||
Trans-urethral | ||||||||
Trans-esoph. (non-Card.) | ||||||||
Musculo-skeletal (Conventional) | N | N | N | N | N | Note 1 | ||
Musculo-skeletal (Superficial) | N | N | N | N | N | Note 1 | ||
Intravascular | ||||||||
Other (Urology) | N | N | N | N | N | Note 1 | ||
Other (Ob/GYN) | N | N | N | N | N | Note 1 | ||
Cardiac | Cardiac Adult | N | N | N | N | N | Note 1 | |
Cardiac Pediatric | N | N | N | N | N | Note 1 | ||
Intravascular (Cardiac) | ||||||||
Trans-esoph. (Cardiac) | ||||||||
Intra-cardiac | ||||||||
Other (Specify) | ||||||||
Peripheral Vessel | Peripheral vessel | N | N | N | N | N | Note 1 | |
Other (Specify) |
N = new indication; P = previously cleared by FDA; E = added under this appendix Note 1: B+M, B+PWD, B+Color Doppler, B+Power Doppler, B+THI,B+Color Doppler+PWD. B+Power Doppler+PWD
Comments: Small Organ: Thyroid, testes and breast
Prescription Use AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) 21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health 510(k) ======================================================================================================================================================================= K131305
6
System: ECO Series Diagnostic Ultrasound Systems Transducer: C3-A, Convex Array
Clinical Application | Mode of Operation | ||||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(Track 1 Only) | Specific | ||||||||
(Tracks 1 & 3) | B | M | PWD | CWD | Color | ||||
Doppler | Power | ||||||||
(Amplitude) | |||||||||
Doppler | Other* | ||||||||
Combined | |||||||||
Ophthalmic | Ophthalmic | ||||||||
Fetal Imaging & | |||||||||
Other | Fetal | N | N | N | N | N | Note 1 | ||
Abdominal | N | N | N | N | N | Note 1 | |||
Intra-operative (Specify) | |||||||||
Intra-operative (Neuro) | |||||||||
Laparoscopic | |||||||||
Pediatric | N | N | N | N | N | Note 1 | |||
Small Organ[1] (Specify) | |||||||||
Neonatal Cephalic | |||||||||
Adult Cephalic | |||||||||
Trans-rectal | |||||||||
Trans-vaginal | |||||||||
Trans-urethral | |||||||||
Trans-esoph. (non-Card.) | |||||||||
Musculo-skeletal (Conventional) | |||||||||
Musculo-skeletal (Superficial) | |||||||||
Intravascular | |||||||||
Other (Urology) | N | N | N | N | N | Note 1 | |||
Other (Ob/GYN) | N | N | N | N | N | Note 1 | |||
Cardiac | Cardiac Adult | ||||||||
Cardiac Pediatric | |||||||||
Intravascular (Cardiac) | |||||||||
Trans-esoph. (Cardiac) | |||||||||
Intra-cardiac | |||||||||
Other (Specify) | |||||||||
Peripheral Vessel | Peripheral vessel | ||||||||
Other (Specify) |
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
P = previously cleared by FDA; N = new indication; E = added under this appendix Note 1: B+M, B+PWD, B+Color Doppler, B+Power Doppler, B+THI.B+Color Doppler+PWD, B+Power Doppler+PWD
Comments: Small Organ: Thyroid, testes and breast
Prescription Use | X |
---|---|
(Part 21 CFR 801 Subpart D) |
AND/OR
Over-The-Counter Use | |
---|---|
(21 CFR 807 Subpart C) |
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
7
ECO Series Diagnostic Ultrasound Systems System: Transducer: MC3-A, Micro-convex Array
Clinical Application | Mode of Operation | ||||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(Track 1 Only) | Specific | ||||||||
(Tracks 1 & 3) | B | M | PWD | CWD | Color | ||||
Doppler | Power | ||||||||
(Amplitude) | |||||||||
Doppler | Other* | ||||||||
Combined | |||||||||
Ophthalmic | Ophthalmic | ||||||||
Fetal Imaging & | Fetal | ||||||||
Other | Abdominal | N | N | N | N | N | Note 1 | ||
Intra-operative (Specify) | |||||||||
Intra-operative (Neuro) | |||||||||
Laparoscopic | |||||||||
Pediatric | |||||||||
Small Organ(1) (Specify) | |||||||||
Neonatal Cephalic | |||||||||
Adult Cephalic | |||||||||
Trans-rectal | |||||||||
Trans-vaginal | |||||||||
Trans-urethral | |||||||||
Trans-esoph. (non-Card.) | |||||||||
Musculo-skeletal (Conventional) | |||||||||
Musculo-skeletal (Superficial) | |||||||||
Intravascular | |||||||||
Other (Urology) | |||||||||
Other (Ob/GYN) | |||||||||
Cardiac | Cardiac Adult | N | N | N | N | N | Note 1 | ||
Cardiac Pediatric | N | N | N | N | N | Note 1 | |||
Intravascular (Cardiac) | |||||||||
Trans-esoph. (Cardiac) | |||||||||
Intra-cardiac | |||||||||
Other (Specify) | |||||||||
Peripheral Vessel | Peripheral vessel | ||||||||
Other (Specify) |
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
N = new indication; P = previously cleared by FDA; E = added under this appendix Note 1: B+M, B+PWD, B+Color Doppler, B+Power Doppler, B+THLB+Color Doppler+PWD, B+Power Doppler+PWD
Comments: Small Organ: Thyroid, testes and breast
Prescription Use AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) 21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health 510(k)________________________________________________________________________________________________________________________________________________________________________
8
ECO Series Diagnostic Ultrasound Systems System:
Transducer: V6-A, Micro-convex Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | |||
---|---|---|---|
Clinical Application | Mode of Operation | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track I Only) | Specific | |||||||
(Tracks 1 & 3) | B | M | PWD | CWD | Color | |||
Doppler | Power | |||||||
(Amplitude) | ||||||||
Doppler | Other* | |||||||
Combined | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal Imaging & | ||||||||
Other | Fetal | N | N | N | N | N | Note 1 | |
Abdominal | ||||||||
Intra-operative (Specify) | ||||||||
Intra-operative (Neuro) | ||||||||
Laparoscopic | ||||||||
Pediatric | ||||||||
Small Organ[1] (Specify) | ||||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | N | N | N | N | N | Note 1 | ||
Trans-vaginal | N | N | N | N | N | Note 1 | ||
Trans-urethral | ||||||||
Trans-esoph. (non-Card.) | ||||||||
Musculo-skeletal (Conventional) | ||||||||
Musculo-skeletal (Superficial) | ||||||||
Intravascular | ||||||||
Other (Urology) | N | N | N | N | N | Note 1 | ||
Other (Ob/GYN) | N | N | N | N | N | Note 1 | ||
Cardiac | Cardiac Adult | |||||||
Cardiac Pediatric | ||||||||
Intravascular (Cardiac) | ||||||||
Trans-esoph. (Cardiac) | ||||||||
Intra-cardiac | ||||||||
Other (Specify) | ||||||||
Peripheral Vessel | Peripheral vessel | |||||||
Other (Specify) |
N = new indication; P = previously cleared by FDA; E = added under this appendix Note 1: B+M. B+PWD, B+Color Doppler, B+Power Doppler, B+THI,B+Color Doppler+PWD, B+Power Doppler+PWD
Comments: Small Organ: Thyroid. testes and breast
Prescription Use _ x AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health 510(k) K131305
9
Transducer: L7M-A, Linear Array
Clinical Application | Mode of Operation | |||||||
---|---|---|---|---|---|---|---|---|
General | Specific | B | M | PWD | CWD | Color | Power | Other* |
(Track 1 Only) | (Tracks 1 & 3) | Doppler | (Amplitude) | |||||
Doppler | Combined | |||||||
Ophthalmic | Ophthalmic | |||||||
Fetal Imaging & | Fetal | |||||||
Other | Abdominal | |||||||
Intra-operative (Specify) | ||||||||
Intra-operative (Neuro) | ||||||||
Laparoscopic | ||||||||
Pediatric | N | N | N | N | N | Note 1 | ||
Small Organ[1] (Specify) | N | N | N | N | N | Note 1 | ||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Card.) | ||||||||
Musculo-skeletal (Conventional) | N | N | N | N | N | Note 1 | ||
Musculo-skeletal (Superficial) | N | N | N | N | N | Note 1 | ||
Intravascular | ||||||||
Other (Urology) | ||||||||
Other (Ob/GYN) | ||||||||
Cardiac | Cardiac Adult | |||||||
Cardiac Pediatric | ||||||||
Intravascular (Cardiac) | ||||||||
Trans-esoph. (Cardiac) | ||||||||
Intra-cardiac | ||||||||
Other (Specify) | ||||||||
Peripheral Vessel | Peripheral vessel | N | N | N | N | N | Note 1 | |
Other (Specify) |
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
N = new indication; P = previously cleared by FDA; E = added under this appendix Note 1: B+M, B+PWD, B+Color Doppler, B+Power Doppler, B+THI,B+Color Doppler+PWD. B+Power Doppler+PWD
Comments: Small Organ: Thyroid, testes and breast
Prescription Use × AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
10
Transducer: L7S-A, Linear Array
Clinical Application | Mode of Operation | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track 1 Only) | Specific | |||||||
(Tracks 1 & 3) | B | M | PWD | CWD | Color | |||
Doppler | Power | |||||||
(Amplitude) | ||||||||
Doppler | Other* | |||||||
Combined | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal Imaging & | ||||||||
Other | Fetal | |||||||
Abdominal | ||||||||
Intra-operative (Specify) | ||||||||
Intra-operative (Neuro) | ||||||||
Laparoscopic | ||||||||
Pediatric | N | N | N | N | N | Note 1 | ||
Small Organ[1] (Specify) | N | N | N | N | N | Note 1 | ||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Card.) | ||||||||
Musculo-skeletal (Conventional) | N | N | N | N | N | Note 1 | ||
Musculo-skeletal (Superficial) | N | N | N | N | N | Note 1 | ||
Intravascular | ||||||||
Other (Urology) | ||||||||
Other (Ob/GYN) | ||||||||
Cardiac | Cardiac Adult | |||||||
Cardiac Pediatric | ||||||||
Intravascular (Cardiac) | ||||||||
Trans-esoph. (Cardiac) | ||||||||
Intra-cardiac | ||||||||
Other (Specify) | ||||||||
Peripheral Vessel | Peripheral vessel | N | N | N | N | N | Note 1 | |
Other (Specify) |
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
P = previously cleared by FDA; N = new indication; E = added under this appendix Note I: B+M, B+PWD, B+Color Doppler, B+Power Doppler, B+THI.B+Color Doppler+PWD, B+Power Doppler+PWD
Comments: Small Organ: Thyroid, testes and breast
x Prescription Use AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
11
Transducer: R7-A, Linear Array
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
General | Specific | B | M | PWD | CWD | Color | Power | Other* | ||
(Track I Only) | (Tracks 1 & 3) | Doppler | (Amplitude) | |||||||
Doppler | Combined | |||||||||
Ophthalmic | Ophthalmic | |||||||||
Fetal Imaging & | Fetal | |||||||||
Other | Abdominal | |||||||||
Intra-operative (Specify) | ||||||||||
Intra-operative (Neuro) | ||||||||||
Laparoscopic | ||||||||||
Pediatric | ||||||||||
Small Organ ( (Specify) | ||||||||||
Neonatal Cephalic | ||||||||||
Adult Cephalic | ||||||||||
Trans-rectal | N | N | N | N | N | Note 1 | ||||
Trans-vaginal | ||||||||||
Trans-urethral | ||||||||||
Trans-esoph. (non-Card.) | ||||||||||
Musculo-skeletal (Conventional) | ||||||||||
Musculo-skeletal (Superficial) | ||||||||||
Intravascular | ||||||||||
Other (Urology) | N | N | N | N | N | Note 1 | ||||
Other (Ob/GYN) | ||||||||||
Cardiac | Cardiac Adult | |||||||||
Cardiac Pediatric | ||||||||||
Intravascular (Cardiac) | ||||||||||
Trans-esoph. (Cardiac) | ||||||||||
Intra-cardiac | ||||||||||
Other (Specify) | ||||||||||
Peripheral Vessel Peripheral vessel | ||||||||||
Other (Specify) |
N = new indication; P = previously cleared by FDA; E == added under this appendix Note 1: B+M, B+PWD, B+Color Doppler, B+Power Doppler, B+THI,B+Color Doppler+PWD, B+Power Doppler+PWD
Comments: Small Organ: Thyroid, testes and breast
Prescription Use × AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) 21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
12
Transducer: P3-A, Phased Array
Clinical Application | Mode of Operation | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track 1 Only) | Specific | |||||||
(Tracks 1 & 3) | B | M | PWD | CWD | Color | |||
Doppler | Power | |||||||
(Amplitude) | ||||||||
Doppler | Other* | |||||||
Combined | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal Imaging & | ||||||||
Other | Fetal | |||||||
Abdominal | ||||||||
Intra-operative (Specify) | ||||||||
Intra-operative (Neuro) | ||||||||
Laparoscopic | ||||||||
Pediatric | ||||||||
Small Organ[1] (Specify) | ||||||||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Card.) | ||||||||
Musculo-skeletal (Conventional) | ||||||||
Musculo-skeletal (Superficial) | ||||||||
Intravascular | ||||||||
Other (Urology) | ||||||||
Other (Ob/GYN) | ||||||||
Cardiac | Cardiac Adult | N | N | N | N | N | Note 1 | |
Cardiac Pediatric | N | N | N | N | N | Note 1 | ||
Intravascular (Cardiac) | ||||||||
Trans-esoph. (Cardiac) | ||||||||
Intra-cardiac | ||||||||
Other (Specify) | ||||||||
Peripheral Vessel | Peripheral vessel | |||||||
Other (Specify) |
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
N = new indication; P = previously cleared by FDA; E = added under this appendix Note 1: B+M, B+PWD, B+Color Doppler, B+Power Doppler, B+THI,B+Color Doppler+PWD, B+Power Doppler+PWD
Comments: Small Organ: Thyroid, testes and breast
× Prescription Use AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) 21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
13
System: ECO Series Diagnostic Ultrasound Systems Transducer: MC6-A, Convex Array
Clinical Application | Mode of Operation | ||||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(Track 1 Only) | Specific | ||||||||
(Tracks 1 & 3) | B | M | PWD | CWD | Color | ||||
Doppler | Power | ||||||||
(Amplitude) | |||||||||
Doppler | Other* | ||||||||
Combined | |||||||||
Ophthalmic | Ophthalmic | ||||||||
Fetal Imaging & | |||||||||
Other | Fetal | ||||||||
Abdominal | N | N | N | N | N | Note 1 | |||
Intra-operative (Specify) | |||||||||
Intra-operative (Neuro) | |||||||||
Laparoscopic | |||||||||
Pediatric | N | N | N | N | N | Note 1 | |||
Small Organ(1) (Specify) | N | N | N | N | N | Note 1 | |||
Neonatal Cephalic | |||||||||
Adult Cephalic | |||||||||
Trans-rectal | |||||||||
Trans-vaginal | |||||||||
Trans-urethral | |||||||||
Trans-esoph. (non-Card.) | |||||||||
Musculo-skeletal (Conventional) | |||||||||
Musculo-skeletal (Superficial) | |||||||||
Intravascular | |||||||||
Other (Urology) | |||||||||
Other (Ob/GYN) | |||||||||
Cardiac | Cardiac Adult | ||||||||
Cardiac Pediatric | N | N | N | N | N | Note 1 | |||
Intravascular (Cardiac) | |||||||||
Trans-esoph. (Cardiac) | |||||||||
Intra-cardiac | |||||||||
Other (Specify) | |||||||||
Peripheral Vessel | Peripheral vessel | ||||||||
Other (Specify) |
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Note 1: B+M, B+PWD, B+Color Doppler, B+Power Doppler, B+TH1,B+Color Doppler+PWD, B+Power Doppler+PWD
Comments: Small Organ: Thyroid, testes and breast
Prescription Use | x |
---|---|
(Part 21 CFR 801 Subpart D) |
AND/OR
Over-The-Counter Use | |
---|---|
(21 CFR 807 Subpart C) |
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR) Sinh -